We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Kodak Recognized for Breast Cancer CR Imaging

By MedImaging staff writers
Posted on 03 Aug 2006
Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, announced that Eastman Kodak Co. More...
(Rochester, NY, USA) has received the 2006 Award for Excellence in Technology in recognition of Kodak's role in advancing the use of computed radiography (CR) for breast cancer detection.

Mammography image quality has become very important for clinicians to understand pathologic processes of the disease, considering the increasing levels of breast cancer. The affordability and versatility of computed CR provides a practical entry into digital mammography and Kodak has installed hundreds of CR systems with its mammography feature outside the United States since its launch in 2005.

"The Kodak DirectView CR mammography feature for CR 850/950/975 systems enables mammography images to be captured digitally with Kodak's CR systems while continuing to use these systems for general radiography exams,” said Frost & Sullivan research analyst Nivedithaa Gopaalakrishnan. "This is reflective of Kodak's commitment to maintain its leadership in mammography imaging as a result of continually bringing new products to market to improve the health of women worldwide.”

Kodak's CR system provides wide exposure leeway that helps in capturing high quality images in single shots, thereby speeding up the process and improving operational efficiency. "The system's spatial resolution provides a detailed representation of tissue, microcalcification and septations in the breast, up to a level of nine to 10 line pairs per millimeter,” stated Ms. Gopaalakrishnan. "This enables physicians to locate changes in the individual calculi and analyze suspect lesions with a resolution quality that equals analog quality.”

For early detection of microcalcifications, high-contrast resolution is vital, particularly in cases of denser glandular parenchyma. The system's ability for higher resolution allows clinicians to examine fine septations, nodular changes, and calculi, which is not possible by traditional imaging.

Each year, Frost & Sullivan presents the Excellence in Technology Award to a company that has pioneered the development and introduction of an innovative technology into the market; a technology that has either impacted or has the potential to impact several market sectors.



Related Links:
Frost & Sullivan
Eastman Kodak

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.